Profile
Quthero aims to disrupt skin care after dermatological procedures, such as laser skin resurfacing and microneedling, and to eliminate scarring post plastic surgery using patented hydrogels incorporating a unique evolutionary-conserved peptide. Quthero’s Q-peptide gel is a novel skin tissue repair gel that, with one application, enables full regrowth of a patient’s natural skin with minimal scarring. Its platform technology is validated with 13 peer-reviewed publications proving the science and three in-vivo models, including an IRB-approved human clinical trial.
Event details
Date: January 9 - 11, 2023
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
13 in total
-
AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health.… -
Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and… -
Cloud DX provides award-winning Virtual Care and Remote Patient Monitoring (RPM) solutions to… -
ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing… -
Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary linear, covalently closed… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
ProteinQure is a computational platform for protein drug discovery that partners with pharma to deliver experimentally… -
QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics… -
Quthero aims to disrupt skin care after dermatological procedures, such as laser skin resurfacing and microneedling,… -
Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies,… -
Spiderwort is a biomaterials company developing a platform of biocompatible, versatile, cellulose-based scaffolds for… -
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…